Dana C. Gilmore
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Dana C. Gilmore has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Christine H. Miller
Department of Pathology, University of Chicago, Chicago, IL, USA
1 shared publication - David E. J. Klawon
David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 500 Main St., Cambridge, MA 02139, USA
1 shared publication - Erin J. Adams
Department of Biochemistry and Molecular Biology, University of Chicago
1 shared publication - Jaime L. Chao
Department of Immunology, University of Washington School of Medicine, Seattle, WA, USA
1 shared publication - John D. Leonard
Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, IL 2
1 shared publication - Kenneth S. Tung
Department of Pathology, University of Virginia, Charlottesville, VA 3
1 shared publication
Latest Publications
- Open Access
- 29 April 2021
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 218 (6)
Altered selection on a single self-ligand promotes susceptibility to organ-specific T cell infiltration
For the large array of self-peptide/MHC class II (pMHC-II) complexes displayed in the body, it is unclear whether CD4+ T cell tolerance must be imparted for each individual complex or whether pMHC-II–nonspecific bystander mechanisms are sufficient to confer tolerance by acting broadly on T cells reactive to multiple self-pMHC-II ligands. Here, via reconstitution of T cell–deficient mice, we demonstrate that altered T cell selection on a single prostate-specific self-pMHC-II ligand renders recipient mice susceptible to prostate-specific T cell infiltration. Mechanistically, this self-pMHC-II complex is required for directing antigen-specific cells into the Foxp3+ regulatory T cell lineage but does not induce clonal deletion to a measurable extent. Thus, our data demonstrate that polyclonal T reg cells are unable to functionally compensate for a breach in tolerance to a single self-pMHC-II complex in this setting, revealing vulnerabilities in antigen-nonspecific bystander mechanisms of immune tolerance.
- 29 April 2021
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 218 (6)
Open AccessAltered selection on a single self-ligand promotes susceptibility to organ-specific T cell infiltration
For the large array of self-peptide/MHC class II (pMHC-II) complexes displayed in the body, it is unclear whether CD4+ T cell tolerance must be imparted for each individual complex or whether pMHC-II–nonspecific bystander mechanisms are sufficient to confer tolerance by acting broadly on T cells reactive to multiple self-pMHC-II ligands. Here, via reconstitution of T cell–deficient mice, we demonstrate that altered T cell selection on a single prostate-specific self-pMHC-II ligand renders recipient mice susceptible to prostate-specific T cell infiltration. Mechanistically, this self-pMHC-II complex is required for directing antigen-specific cells into the Foxp3+ regulatory T cell lineage but does not induce clonal deletion to a measurable extent. Thus, our data demonstrate that polyclonal T reg cells are unable to functionally compensate for a breach in tolerance to a single self-pMHC-II complex in this setting, revealing vulnerabilities in antigen-nonspecific bystander mechanisms of immune tolerance.